Co-Diagnostics, Inc. - 8-K Filing
Co-Diagnostics shareholders approve 2025 Equity Incentive Plan amendment and authorization for potential reverse stock splits. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 of this Current Report on Form 8-K, 9.01 Financial Statements and Exhibits)
Tickers: $CODX